Michael Mollerus
Lawyers
Filters
General Dynamics $4 billion notes offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in an SEC-registered offering by General Dynamics Corporation of $750 million aggregate…
SS&C acquisition of Captricity
Davis Polk advised SS&C Technologies Holdings, Inc. on its acquisition of Captricity. Financial terms of the transaction were not disclosed.
SS&C is a global provider of services…
Honeywell International €1 billion notes offering
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Honeywell International Inc. of €500 million aggregate principal amount of its 0.000…
Mobile Mini merger of equals with WillScot
Davis Polk is advising Mobile Mini, Inc. on its all-stock merger of equals with WillScot Corporation to form a combined company with an implied total enterprise value of approximately $6.6…
Citrix $750 million notes offering
Davis Polk advised the underwriters in connection with an SEC-registered offering by Citrix Systems, Inc. of $750 million aggregate principal amount of its 3.300% senior notes due 2030…
Morgan Stanley $13 billion acquisition of E*TRADE Financial
Davis Polk is advising Morgan Stanley on its $13 billion acquisition of E*TRADE Financial Corporation. The transaction is expected to close in the fourth quarter of 2020, subject to…
Uniti $2.25 billion senior secured notes offering and credit agreement amendment
Davis Polk advised Uniti Group Inc. in connection with a Rule 144A and Regulation S offering of $2.25 billion aggregate principal amount of 7.875% senior secured notes due 2025 issued by…
Clarivate Analytics $559 million share offering
Davis Polk advised Clarivate Analytics Plc in connection with the $559 million SEC-registered offering of 27,600,000 of its ordinary shares. The ordinary shares are listed on the New York…
Applied Therapeutics $143.4 million stock offering
Davis Polk advised the underwriters in connection with the SEC-registered offering of 3,152,712 shares of common stock of Applied Therapeutics, Inc., including 411,223 shares of common…
Embotelladora Andina $300 million senior notes offering
Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by Embotelladora Andina S.A. of an aggregate principal amount of $300 million of 3.950%…